Uger Robert 4
4 · Trillium Therapeutics Inc. · Filed Apr 9, 2021
Insider Transaction Report
Form 4
Uger Robert
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Shares
2021-04-07$0.30/sh+3,646$1,098→ 3,646 total - Sale
Common Shares
2021-04-07$10.82/sh−3,646$39,450→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-07−3,646→ 113,021 totalExercise: $0.30Exp: 2029-11-07→ Common Shares (3,646 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The exercise price of these options is $0.38 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7926 USD.
- [F3]25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months.